東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Rare diseases = integrative PPPM app...

Ozguc, Meral.

Linked to FindBook

Google Book

Amazon

博客來

Rare diseases = integrative PPPM approach as the medicine of the future /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Rare diseases/ edited by Meral Ozguc.
Reminder of title:	integrative PPPM approach as the medicine of the future /
other author:	Ozguc, Meral.
Published:	Dordrecht :Springer Netherlands : : 2015.,
Description:	xviii, 208 p. :ill., digital ;24 cm.
[NT 15003449]:	National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.
Contained By:	Springer eBooks
Subject:	Rare diseases. -
Online resource:	http://dx.doi.org/10.1007/978-94-017-9214-1
ISBN:	9789401792141 (electronic bk.)

Rare diseases = integrative PPPM approach as the medicine of the future /
Rare diseasesintegrative PPPM approach as the medicine of the future /[electronic resource] :edited by Meral Ozguc. - Dordrecht :Springer Netherlands :2015. - xviii, 208 p. :ill., digital ;24 cm. - Advances in predictive, preventive, and personalised medicine,v.62211-3495 ;. - Advances in predictive, preventive, and personalised medicine ;v.6..

National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.

This book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent proof-of-principles for the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongst other topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, doctor-patient collaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value.

ISBN: 9789401792141 (electronic bk.)

Standard No.: 10.1007/978-94-017-9214-1doiSubjects--Topical Terms:

1243988
Rare diseases.

LC Class. No.: RC48.8

Dewey Class. No.: 616

Rare diseases = integrative PPPM approach as the medicine of the future /
LDR:03529nmm a2200349 a 4500 001 1994355
003 DE-He213
005 20150605161922.0
006 m d
007 cr nn 008maaau
008 151019s2015 ne s 0 eng d
020 $a 9789401792141 (electronic bk.)
020 $a 9789401792134 (paper)
024 7 $a 10.1007/978-94-017-9214-1 $2 doi
035 $a 978-94-017-9214-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC48.8
072 7 $a PS $2 bicssc
072 7 $a PDN $2 bicssc
072 7 $a SCI008000 $2 bisacsh
072 7 $a SCI043000 $2 bisacsh
082 0 4 $a 616 $2 23
090 $a RC48.8 $b .R221 2015
245 0 0 $a Rare diseases $h [electronic resource] : $b integrative PPPM approach as the medicine of the future / $c edited by Meral Ozguc.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a xviii, 208 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in predictive, preventive, and personalised medicine, $x 2211-3495 ; $v v.6
505 0 $a National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.
520 $a This book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent proof-of-principles for the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongst other topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, doctor-patient collaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value.
650 0 $a Rare diseases. $3 1243988
650 1 4 $a Life Sciences. $3 890838
650 2 4 $a Biological Techniques. $3 900035
650 2 4 $a Cell Biology. $3 892383
650 2 4 $a Pediatrics. $3 559143
650 2 4 $a Metabolic Diseases. $3 895373
700 1 $a Ozguc, Meral. $3 2133128
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in predictive, preventive, and personalised medicine ; $v v.6. $3 2133129
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-9214-1
950 $a Medicine (Springer-11650)